176 related articles for article (PubMed ID: 7032929)
1. Surgical adjuvant trials in the United States.
Rozencweig M; Von Hoff DD; Allegra JC; Muggia FM
Eur J Cancer (1965); 1980; Suppl 1():173-7. PubMed ID: 7032929
[No Abstract] [Full Text] [Related]
2. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
[No Abstract] [Full Text] [Related]
3. Adjuvant chemotherapy with four drugs for stage 2 breast cancer.
Wheeler TK; Edelstyn GA; Bates TS; Brinkley D; Evans RG; Kitchen G; MacRae KD; Nicol NT; Spittle M; Wheeler TK
Eur J Cancer (1965); 1980; Suppl 1():161-3. PubMed ID: 7032926
[No Abstract] [Full Text] [Related]
4. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
Hubay CA; Pearson OH; Marshall JS; Rhodes RS; Debanne SM; Mansour EG; Hermann RE; Jones JC; Flynn WJ; Eckert C; McGuire WL
Eur J Cancer (1965); 1980; Suppl 1():189-95. PubMed ID: 7032932
[No Abstract] [Full Text] [Related]
5. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
Mouridsen HT; Palshof T; Engelsman E; Sylvester R
Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
[No Abstract] [Full Text] [Related]
6. Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
Mouridsen HT; Palshof T; Brahm M; Rahbek I
Cancer Treat Rep; 1977; 61(1):47-50. PubMed ID: 324620
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
Mouridsen HT; Palshof T
Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
[No Abstract] [Full Text] [Related]
8. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
[No Abstract] [Full Text] [Related]
9. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
Heuson JC; Sylvester R; Engelsman E
Eur J Cancer (1965); 1980; Suppl 1():113-7. PubMed ID: 7032920
[No Abstract] [Full Text] [Related]
10. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
Brunner KW; Martz G; Senn HJ; Obrecht P; Alberto P; Melchert F
Internist (Berl); 1973 Dec; 14(12):643-52. PubMed ID: 4593011
[No Abstract] [Full Text] [Related]
11. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant treatment of cancer. II. Breast carcinoma.
Viola MV; Nystrom JS
Conn Med; 1977 Jun; 41(6):333-5. PubMed ID: 872584
[No Abstract] [Full Text] [Related]
13. [Combination chemotherapy in advanced carcinoma of the breast].
Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L
Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643
[No Abstract] [Full Text] [Related]
14. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
Smalley RV; Bartolucci AA
Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
[No Abstract] [Full Text] [Related]
15. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
Heuson JC; Paridaens R
Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
[No Abstract] [Full Text] [Related]
16. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Lee JM; Abeloff MD; Lenhard RE; Baker RR
Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
[No Abstract] [Full Text] [Related]
17. [Cytostatic combination therapy in metastatic breast cancer].
Mouridsen HT
Ugeskr Laeger; 1973 Jun; 135(25):1336-40. PubMed ID: 4757127
[No Abstract] [Full Text] [Related]
18. Combination chemotherapy for disseminated carcinoma of the breast.
Lozada JA; Grillo-López A; Vélez-Garciá E
Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588
[No Abstract] [Full Text] [Related]
19. Breast cancer 1984: state of the art.
Sledge GW
Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
[No Abstract] [Full Text] [Related]
20. Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of Milan.
Rossi A; Bonadonna G; Tancini G; Bajetta E; Marchini S; Valagussa P; Veronesi U
Eur J Cancer (1965); 1980; Suppl 1():149-56. PubMed ID: 7032924
[No Abstract] [Full Text] [Related]
[Next] [New Search]
